Sanaria is grabbing headlines with its approach to fighting malaria. Researchers for the company have developed a process to create weakened parasites that create an immune response sufficient to protect 90 percent of patients for a 10-month period. The company's founder, Steven Hoffman, says that the vaccine could be a huge life saver in Africa. Malaria kills about two million people each year, and most of the victims are children.
- read the report [1] from AHN
Related Articles:
Herbal drug used to model new malaria drug. Report [2]
Genome map completed on malaria parasite. Report [3]
WHO: Infectious disease a growing threat. Report [4]
Links:
[1] http://www.allheadlinenews.com/articles/7008981619
[2] http://www.fiercebioresearcher.com/story/herbal-drug-used-to-model-new-malaria-drug/2007-04-24
[3] http://www.fiercebioresearcher.com/story/genome-map-completed-on-malaria-parasite/2006-12-14
[4] http://www.fiercebiotech.com/story/who-infectious-disease-growing-threat/2007-08-24